午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook >> journal list >> Chemical Engineering Journal >>article
Chemical Engineering Journal

Chemical Engineering Journal

IF: 13.3
Download PDF

Designed tumor microenvironment-remodeling bispolyphenol nanoparticles combined with αPD-L1 for enhanced melanoma immunotherapy

Published:9 December 2024 DOI: 10.1016/j.cej.2024.158442
Yanzhu Wang, Linghe Zang, Liyuan Guan, Xihang Ren, Zongmin Xia, Zhou Li, Zhaoxu Meng, He Lian

Abstract

The efficacy of αPD-L1, an immune checkpoint inhibitor, in the treatment of melanoma is limited by individual patient variations and tumor immunosuppressive cells. Consequently, current immunotherapy of melanoma is far from satisfactory. In this study, bispolyphenol nanoparticles (Phl-CaCO3@Lut-Cu NPs) were constructed by wrapping a luteolin-copper (Lut-Cu) network around the surface of phloretin-loaded calcium carbonate (Phl-CaCO3) nanoparticles. Upon entering tumor cells, Phl-CaCO3@Lut-Cu nanoparticles efficiently released Cu2+, phloretin (Phl), and luteolin (Lut) due to the acid-responsive properties of calcium carbonate and the metal-phenolic network. The copper ions mediated cuproptosis by binding to dihydrolipoamide acetyltransferase and induced cellular immune responses by promoting release of damage-associated molecular patterns (DAMPs). In addition, Phl blocked glucose transport by inhibiting glucose transporter 1 activity, thereby disrupting the energy supply process in tumor cells. Simultaneously, Lut inhibited expression of hypoxia-inducible factor-1α, negatively regulating aerobic glycolysis. This study aimed to reshape the tumor microenvironment by exploring the synergistic effects of cuproptosis and dual glycolysis inhibition, enhancing the T cell-mediated immune response, and suppressing tumor cell growth when combined with αPD-L1. This study provides a new perspective and strategy for melanoma immunotherapy.

Substances (2)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Tris(hydroxymethyl)aminomethane 77-86-1 C4H11NO3 1137 suppliers $5.00-$8920.00
FETUIN 9014-81-7 NULL 66 suppliers $37.07-$4380.00

Similar articles

IF:6.9

Role of ginsenoside Rh2 in tumor therapy and tumor microenvironment immunomodulation

Biomedicine & Pharmacotherapy Sun Xiaodan , Cheng Ying,etc Published: 1 December 2022
IF:5.3

Liposomes-mediated enhanced antitumor effect of docetaxel with BRD4-PROTAC as synergist for breast cancer chemotherapy/immunotherapy

International Journal of Pharmaceutics Xixi Chen, Fang Li,etc Published: 19 November 2024
IF:10

Hybrid Cell Membrane‐Coated Nanoparticles for Synergizing Sonodynamic Therapy and Immunotherapy against Triple‐Negative Breast Cancer

Advanced Healthcare Materials Jiali Gong, Danling Cheng,etc Published: 21 November 2024